Multifactorial risk profile for bone fractures in primary hyperparathyroidism

被引:0
|
作者
Erik Nordenström
Johan Westerdahl
Birger Lindergård
Pia Lindblom
Anders Bergenfelz
机构
[1] Lund University Hospital,Department of Surgery
[2] Lund University Hospital,Department of Internal Medicine
来源
World Journal of Surgery | 2002年 / 26卷
关键词
Fracture Risk; Bone Mineral Content; Bone Fracture; Clavicle Fracture; pHPT Patient;
D O I
暂无
中图分类号
学科分类号
摘要
Primary hyperparathyroidism (pHPT) is associated with an increased fracture risk, and decreased bone density thus has been considered an indication for surgery. However, many pHPT patients have a multifactorial risk profile for osteoporosis and bone fractures. The aim of the present study was to evaluate variables associated with fracture risk within the group of pHPT patients. A series of 203 consecutive patients operated for pHPT were investigated with bone mineral content and biochemical and clinical risk factors for bone fracture. Seventeen patients (8%) had a history of at least one bone fracture up to 5 years before pHPT surgery. Twenty-six patients (13%) had a history of at least one fracture during the 10-year period prior to surgery. In the univariate analyses corticosteroid treatment, serum levels of alkaline phosphatase, 25-hydroxyvitamin D3, type I collagen telopeptide, and bone mineral content were found to be associated with a history of bone fractures up to 10 years before surgery. Additionally, age and menopausal status were of importance for fractures during the 10-year-period, whereas a history of cardiovascular disease was important for fractures during the 5-year-period prior to surgery. Multivariate analyses showed that serum level of PTH was independently associated with bone fractures during the 5-year period prior to pHPT surgery and further that serum level of 25-hydroxyvitamin D3 was associated with fractures up to 10 years before surgery. In conclusion, serum levels of 25-hydroxyvitamin D3 and PTH were independently associated with a history of bone fractures in pHPT. These variables should be considered when evaluating patients for parathyroid surgery.
引用
收藏
页码:1463 / 1467
页数:4
相关论文
共 50 条
  • [1] Multifactorial risk profile for bone fractures in primary hyperparathyroidism
    Nordenström, E
    Westerdahl, J
    Lindergård, B
    Lindblom, P
    Bergenfelz, A
    WORLD JOURNAL OF SURGERY, 2002, 26 (12) : 1463 - 1467
  • [2] The risk of fractures in postmenopausal women with primary hyperparathyroidism
    De Geronimo, Simona
    Romagnoli, Elisabetta
    Diacinti, Daniele
    D'Erasmo, Emilio
    Minisola, Salvatore
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (03) : 415 - 420
  • [3] Bone insufficiency fractures as an inaugural manifestation of primary hyperparathyroidism
    Lafforgue, P
    Pham, T
    Denizot, A
    DaumenLegre, V
    Acquaviva, PC
    REVUE DU RHUMATISME, 1996, 63 (7-8): : 475 - 479
  • [4] The Risk of Fractures in Primary Hyperparathyroidism: A Meta-Analysis
    Narayanan, Niya
    Palui, Rajan
    Merugu, Chandhana
    Kar, Sitanshu Sekhar
    Kamalanathan, Sadishkumar
    Sahoo, Jayaprakash
    Selvarajan, Sandhiya
    Naik, Dukhabandhu
    JBMR PLUS, 2021, 5 (04)
  • [5] RISK OF AGE-RELATED FRACTURES IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM
    MELTON, LJ
    ATKINSON, EJ
    OFALLON, WM
    HEATH, H
    ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (11) : 2269 - 2273
  • [7] MILD ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM IS NOT A RISK FACTOR FOR VERTEBRAL FRACTURES
    WILSON, RJ
    RAO, S
    ELLIS, B
    KLEEREKOPER, M
    PARFITT, AM
    ANNALS OF INTERNAL MEDICINE, 1988, 109 (12) : 959 - 962
  • [8] Normocalcemic primary hyperparathyroidism with fractures
    Wu, PH
    Wang, CJ
    JOURNAL OF ARTHROPLASTY, 2002, 17 (06): : 805 - 809
  • [9] Bone and primary hyperparathyroidism
    Cormier, Catherine
    Koumakis, Eugenie
    JOINT BONE SPINE, 2022, 89 (01)
  • [10] Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis
    Ejlsmark-Svensson, H.
    Rolighed, L.
    Harslof, T.
    Rejnmark, L.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (06) : 1053 - 1060